Irisin in metabolic diseases

SA Polyzos, AD Anastasilakis, ZA Efstathiadou… - Endocrine, 2018 - Springer
Introduction Irisin is a myokine/adipokine induced by the exercise in mice and humans,
which is proposed to induce “browning” of white adipose tissue, its primary target, thus …

Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population

I Akhlaghipour, AR Bina, MR Mogharrabi, A Fanoodi… - Human Genomics, 2022 - Springer
Diabetes is a chronic metabolic disorder that leads to the dysfunction of various tissues and
organs, including eyes, kidneys, and cardiovascular system. According to the World Health …

Irisin as a novel biomarker of subclinical atherosclerosis, cardiovascular risk and severe disease in axial spondyloarthritis

S Remuzgo-Martínez, J Rueda-Gotor… - Frontiers in …, 2022 - frontiersin.org
Introduction Patients with axial spondyloarthritis (axSpA) have a high disease burden mainly
due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads …

Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target

X Zhang, C Hu, H Wu, Z Ma, Q Tang - Acta Pharmacologica Sinica, 2021 - nature.com
Cardiovascular and metabolic diseases are the leading causes of death and disability
worldwide and impose a tremendous socioeconomic burden on individuals as well as the …

The association between serum irisin levels and cardiovascular disease in diabetic patients

ZM Khorasani, RK Bagheri, MA Yaghoubi… - Diabetes & Metabolic …, 2019 - Elsevier
Background Cardiovascular disease is the most common cause of mortality and morbidity in
diabetic patients. Insulin resistance has been shown to be reduced by the secretion of irisin …

Association between serum irisin and diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis

R Wang, H Liu - Hormone and Metabolic Research, 2021 - thieme-connect.com
Irisin, an emerging adipokine, has been involved in the pathogenesis of type 2 diabetes
mellitus (T2DM). However, previous studies evaluating the association between irisin and …

Associations between rs3480 and rs16835198 gene polymorphisms of FNDC5 with type 2 diabetes mellitus susceptibility: a meta-analysis

X Yang, L Ni, J Sun, X Yuan, D Li - Frontiers in Endocrinology, 2022 - frontiersin.org
Background FNDC5 is a novel and important player in energy regulation related to glucose
metabolism and insulin levels. Thus, it may affect the incidence of type 2 diabetes mellitus …

Lower circulating irisin levels in type 2 diabetes mellitus patients with chronic complications: A meta-analysis

Q Hou, R Song, X Zhao, C Yang, Y Feng - Heliyon, 2023 - cell.com
Purpose The aim of this study was to provide evidence of the differences in circulating irisin
levels between type 2 diabetes mellitus (T2DM) patients with and without chronic …

Mechanistic insights into the beneficial effects of curcumin on insulin resistance: opportunities and challenges

P Balakumar, K Venkatesan, NA Khan… - Drug Discovery …, 2023 - Elsevier
Highlights•T2DM is considered a debilitating metabolic disorder characterized by insulin
resistance.•Evidence suggests potential beneficial effects of curcumin on insulin …

Does iris (in) bring bad news or good news?

S Buscemi, D Corleo, C Buscemi… - Eating and Weight …, 2018 - Springer
Irisin, a novel myokine produced in response to physical activity, promotes white-to-brown
fat transdifferentiation. The name irisin referred to the ancient Greek goddess Iris, the …